These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38040880)

  • 21. Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.
    Deux JF; Audard V; Brugières P; Habibi A; Manea EM; Guillaud-Danis C; Godeau B; Galactéros F; Stehlé T; Lang P; Grimbert P; Audureau E; Rahmouni A; Bartolucci P
    Am J Kidney Dis; 2017 Jan; 69(1):51-59. PubMed ID: 27663041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Procalcitonin as a diagnostic marker for infection in sickle cell disease.
    Maharaj S; Chang S
    Expert Rev Hematol; 2022 Jun; 15(6):559-564. PubMed ID: 35579470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lactate dehydrogenase in sickle cell disease.
    Stankovic Stojanovic K; Lionnet F
    Clin Chim Acta; 2016 Jul; 458():99-102. PubMed ID: 27138446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and Laboratory Predictors of Painful Vaso-Occlusive Crisis Among Sickle Cell Disease Patients: A Single-Center Study in Saudi Arabia.
    Zakaria O; Buhalim RA; Almulhim F; Al Jabr FA; Alrashid A; Almutairi M
    Cureus; 2021 May; 13(5):e14980. PubMed ID: 34123674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of patient-reported vaso-occlusive crisis day as an endpoint in sickle cell disease studies.
    Coyne KS; Currie BM; Callaghan M; Wyrwich KW; Pease S; Baker CL; Arkin S; Pittman DD
    Eur J Haematol; 2022 Sep; 109(3):226-237. PubMed ID: 35569114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole blood transcriptomic analysis reveals PLSCR4 as a potential marker for vaso-occlusive crises in sickle cell disease.
    Abdulwahab H; Aljishi M; Sultan A; Al-Kafaji G; Sridharan K; Bakhiet M; Taha S
    Sci Rep; 2021 Nov; 11(1):22199. PubMed ID: 34772994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sickle cell disease complications: Prevalence and resource utilization.
    Shah N; Bhor M; Xie L; Paulose J; Yuce H
    PLoS One; 2019; 14(7):e0214355. PubMed ID: 31276525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis.
    Musa BO; Onyemelukwe GC; Hambolu JO; Mamman AI; Isa AH
    Clin Vaccine Immunol; 2010 Apr; 17(4):602-8. PubMed ID: 20130127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment with recombinant ADAMTS13, alleviates hypoxia/reoxygenation-induced pathologies in a mouse model of human sickle cell disease.
    Rossato P; Glantschnig H; Canneva F; Schuster M; Coulibaly S; Schrenk G; Voelkel D; Dockal M; Plaimauer B; Rottensteiner H; Gritsch H; Federti E; Matte A; De Franceschi L; Scheiflinger F; Hoellriegl W
    J Thromb Haemost; 2023 Feb; 21(2):269-275. PubMed ID: 36700507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased Circulating Copeptin Levels Are Associated with Vaso-Occlusive Crisis and Right Ventricular Dysfunction in Sickle Cell Anemia.
    Deveci OS; Ozmen C; Karaaslan MB; Celik AI; Rahimova H; Akray A; Tepe O; Gurkan E; Deniz A
    Med Princ Pract; 2022; 31(1):47-53. PubMed ID: 34852350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study of hypercoagulability change in steady state and during vaso-occlusive crisis among Sudanese patients living with sickle cell disease.
    Mohamed EA; Elgari MM; Babker AM; Waggiallah HA
    Afr Health Sci; 2020 Mar; 20(1):392-396. PubMed ID: 33402927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heart rate variability study in adult Nigerian subjects with sickle cell disease during vaso-occlusive crisis.
    Adebiyi AA; Oyebowale OM; Olaniyi AJ; Falase AO
    Niger Postgrad Med J; 2019; 26(1):8-12. PubMed ID: 30860193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fetal hemoglobin and alpha thalassemia modulate the phenotypic expression of HbSD-Punjab.
    Patel DK; Purohit P; Dehury S; Das P; Dutta A; Meher S; Patel S; Bag S; Mashon RS; Das K
    Int J Lab Hematol; 2014 Aug; 36(4):444-50. PubMed ID: 24245819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma histamine elevation in a large cohort of sickle cell disease patients.
    Allali S; Lionnet F; Mattioni S; Callebert J; Stankovic Stojanovic K; Bachmeyer C; Arlet JB; Brousse V; de Montalembert M; Chalumeau M; Grateau G; Maciel TT; Launay JM; Hermine O; Georgin-Lavialle S
    Br J Haematol; 2019 Jul; 186(1):125-129. PubMed ID: 30924132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multimodal pain protocol for treatment of vaso-occlusive crisis in patients with sickle cell disease: Implementation and evaluation.
    Admiraal M; van Daalen J; Ritt MWJ; Dekker J; van Tuijn CFJ; Nur E; Hollmann MW; Hermanns H; Hermanides J; Biemond BJ
    Eur J Haematol; 2023 Sep; 111(3):382-390. PubMed ID: 37277324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of treatment patterns, healthcare resource utilization and cost of illness for sickle cell disease in Ghana: a private medical insurance claims database study.
    Marfo K; Dei-Adomakoh Y; Segbefia C; Dwomoh D; Edgal A; Ampah N; Ramachandrachar BC; Subramanyam K; Natarajan A; Egbujo O; Ataga KI
    BMC Health Serv Res; 2023 Sep; 23(1):1018. PubMed ID: 37735428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients.
    Bartolucci P; Habibi A; Khellaf M; Roudot-Thoraval F; Melica G; Lascaux AS; Moutereau S; Loric S; Wagner-Ballon O; Berkenou J; Santin A; Michel M; Renaud B; Lévy Y; Galactéros F; Godeau B
    EBioMedicine; 2016 Aug; 10():305-11. PubMed ID: 27412264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of immature granulocyte percentage in predicting acute chest syndrome and the severity of the vaso-occlusive crisis in sickle cell disease.
    Karahan F; Ünal S; Topçu DB; Öztaş Y; Bozlu G
    Turk J Pediatr; 2022; 64(1):92-97. PubMed ID: 35286035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein Z polymorphisms associated with vaso-occlusive crisis in young sickle cell disease patients.
    Mahdi N; Abu-Hijleh TM; Abu-Hijleh FM; Sater MS; Al-Ola K; Almawi WY
    Ann Hematol; 2012 Aug; 91(8):1215-20. PubMed ID: 22576309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis.
    Shah SP; Twilla JD; Kemp L; Phelps GL; Reaves A
    J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):201-207. PubMed ID: 30896312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.